Clinical Trial Details

EORTC-1513-BCG

Back to Clinical Trials Database

PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of palbociclib with adjuvant endocrine therapy versus endocrine therapy alone for hormone receptor positive (HR+)/ human epidermal growth factor receptor 2 (HER2)-negative early breast Cancer

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 14-Nov-2016
Data management at EORTC No
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 460 - All Groups: 5600
Treatment Drug
Palbociclib
Study Staff Fatima Cardoso (Study Coordinator) , Champalimaud Clinical Center, Lisboa
Christine Bourguignon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Laura De Meulemeester (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Coralie Poncet (Statistician) , EORTC Headquarters, Brussels
Type of cancer Breast
Participating groups EORTC Breast Cancer Group
Breast International Group
Austrian Breast and Colorectal Cancer Study Group
Recruiting centers Azienda Ospedaliera Città della Salute e della Scienza di Torino - Gynecologic Oncology Ospedale S.Anna and University of Turin (Torino, Italy)
CHU Saint-Pierre-Site Porte de Hal (Brussels, Belgium)
CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
Champalimaud Clinical Center (Lisboa, Portugal)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
GasthuisZusters Antwerpen - Sint-Augustinus (Wilrijk, Belgium)
Grand Hopital de Charleroi - Site Notre Dame (Charleroi, Belgium)
Hopitaux universitaires de Geneve - HUG - site de Cluse-Roseraie (Geneve, Switzerland)
Institut Jules Bordet (Anderlecht, Belgium)
Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom)
Nottingham University Hospitals NHS Trust - City Hospital (Nottingham, United Kingdom)
Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium)
Rabin Medical Center - Tel Aviv (Petah Tikva, Israel)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Univ. of Florence -Azienda Ospedaliero-Universitaria Careggi (Firenze, Italy)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
Protocol summary http://clinicaltrials.gov/study/NCT02513394
NCT number NCT02513394
EudraCT 2014-005181-30
Financial Support Educational Grant